Cross-Over Studies: Clinical Trials

2 trials of Cross-Over Studies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1

Follow Cross-Over Studies: new trials by email Literature Review of Cross-Over Studies trials Research Report on Cross-Over Studies

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.
Eplerenone 50mg/day (cross over design), Period without eplerenone (cross over design) - Kidney Transplantation for More Than One Year, Patients with a Kidney Transplantation on Cyclosporine
Phase 3RecruitingCentral Hospital, Nancy, France362021-10-122025-02-12
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
4.5 mg Naltrexone, Naltrexone - Multiple Sclerosis
Phase 3CompletedUniversity of California, San Francisco802007-02-012008-05-19

Conditions studied

Multiple Sclerosis (1)

Sponsors

Central Hospital, Nancy, France (1)  ·  University of California, San Francisco (1)

Countries

France (1)  ·  United States (1)

Top investigators

Bruce Kornyeyva, MD, PhD (1)

Results publications

PMID 39082471, PMID 41204172

NIH funding

2019 (1)